Lots of meat in the pres. that as far a I know have not been disclosed of yet including pricing, product launch underway, clinical trial targets, the creation of the clinical and sales team in the U.S and that the FDA third round questioning is underway.
The Australan market is obviously a "test market" - been very successful.
Ann: CEO March 2014 Investor Presentation , page-2
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DVL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.367M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 781055 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 246683 | 2 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| DVL (ASX) Chart |
Day chart unavailable